Pregnant people with or without antiphospholipid antibodies
Part of Bones, joints & muscles, Immune system & allergy, Skin, Women’s health & pregnancy clinical trials.
This study is looking at pregnancy outcomes in people who are pregnant and either have antiphospholipid antibody syndrome (APS) or do not have APS but do have prior full-term pregnancies. It may help doctors understand risks and how to manage pregnancies in these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and between 18 and 45 years old
- You fit one of these groups: (1) diagnosed with primary APS, or (2) not diagnosed with APS but had at least one prior full-term pregnancy
- You have not had prior blood clots (thrombotic event)
- You do not have certain long-term medical problems during pregnancy, like long-term high blood pressure or certain nerve/brain problems
- Your pregnancy was not achieved using PMA (assisted reproduction)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether certolizumab can improve pregnancy outcomes in people with antiphospholipid syndrome (APS). It targets pregnancy complications related to APS while closely checking safety, infections, and certain health conditions.
This study looks at how the immune system works during pregnancy, focusing on women at high risk for preeclampsia. Researchers want to understand immune changes before any treatment is started.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This trial looks at people who have symptoms of antiphospholipid syndrome (APS) but test negative for the usual antibodies. It will compare these patients to those with positive antibody tests to better understand the condition and improve diagnosis and treatment.
This study looks at people with preeclampsia during pregnancy and how their lung blood pressure and related symptoms change after delivery. It may help doctors better monitor and manage postpartum risks, especially involving the heart and lungs.
This study looks for factors that may predict how pregnancy turns out in people with lupus (SLE) and/or antiphospholipid syndrome (APS). It may help doctors better understand what to monitor in early pregnancy to support healthier outcomes.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.